Amgen seeks to market osteoporosis drug in Japan
Thousand Oaks biotech giant Amgen is seeking marketing approval in Japan for osteoporosis drug romosozumab, the company announced on Dec. 20. Amgen submitted the request to the Pharmaceuticals and Medical Devices Agency in Japan, where an estimated 12 million people have a high risk of bone fracture. The company is co-developing the drug worldwide with Euronext Read More →
Lockheed Martin wins contract for F-35 logistics
Lockheed Martin was awarded a contract valued at $181.2 million by the Naval Air Systems Command to provide logistic services for its F-35 Lightning II aircraft. The aerospace and defense company with operations in Santa Barbara will conduct ground maintenance, supply chain management, pilot and maintainer training and support and other functions, according to a Read More →
QAD software streamlines Yamaha Motor’s data analysis
Manufacturing software provider QAD announced Yamaha Motor Manufacturing Corporation USA as a customer Dec. 7, using its Cloud QMS software at its Newnan, Georgia facility. The recreational and all-terrain vehicle manufacturer deployed the software for purchasing and data analysis, reducing time on requests information, Wayne Pierce, senior division manager of purchasing for YMMC, said in Read More →
Inphi completes acquisition of ClariPhy Communications
Inphi’s acquisition of ClariPhy Communications, valued at $277 million in addition to the assumption of some liabilities, was completed Dec. 12. The deal, announced Nov. 1, gives the semiconductor producer with operations in Westlake Village access to products that are complimentary to its own, providing high-performance but low-power platforms for its customers, President and CEO Read More →
Teledyne acquires e2v Technologies
Thousand Oaks-based Teledyne Technologies acquired the British high performance image sensor manufacturer e2v Technologies in an all-cash deal, the companies announced on Dec. 12. Under the terms of the deal, e2v’s ordinary shareholders will receive 275 pence in cash for each e2v share valuing the ordinary share capital of e2v at approximately 620 million British Read More →
Diagnostic companies aim to disrupt medical industry
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Startup’s app users get health advice based on genetics
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
